Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announcement on the 2026 Remuneration Plan for Directors and Senior Management
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false statements, misleading representations, or material omissions.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held its Third Meeting of the Ninth Board of Directors on April 27, 2026. The meeting deliberated on the "Proposal on the Remuneration Plan for Directors and Senior Management." All directors abstained from voting on this proposal, which will be directly submitted to the Company's 2025 Annual General Meeting of Shareholders for deliberation. The relevant details of the Company's 2026 Remuneration Plan for Directors and Senior Management are hereby announced as follows:
I. Scope of Application All directors and senior management.
II. Validity Period January 1, 2026, to December 31, 2026.
III. Remuneration Plan
(I) Corresponding remuneration standards shall be determined based on the nature of work of directors and senior management, as well as the responsibilities and risks they undertake. The remuneration of the Company's directors and senior management should be in line with market development, match the Company's operating performance and individual performance, and be consistent with the Company's sustainable development.